The Study of rHuTPO/rHuIL-11 in the Treatment for Chemotherapy-induced Thrombocytopenia in Patients With NSCLC
Clinical trial NCT02344979 · UNKNOWN
Trial details
- NCT number
- NCT02344979
- Sponsor
- Shenyang Sunshine Pharmaceutical Co., LTD.
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2009-05-01
- Primary completion
- 2015-06-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.